1173018-79-5
1173018-79-5
Chemical Structure
Paraxanthine-13C4,15N3
- CAS No.: 1173018-79-5
- Formula:C313C4H8N15N3O2
- Molecular Weight:187.11
IUPAC Name: 1,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione-2,4,5,6-13C4-1,3,9-15N3
InChIKey: QUNWUDVFRNGTCO-UDYOVZSYSA-N
SMILES: CN1C=[15N][13C]([15NH][13C]2=O)=[13C]1[13C]([15N]2C)=O
Biological Activity: Paraxanthine-13C4,15N3 is the 13C-labeled and 15N-labeled Paraxanthine. Paraxanthine, a caffeine metabolite, provides protection against Dopaminergic cell death via stimulation of Ryanodine Receptor Channels.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Paraxanthine-13C4,15N3 | 99.80% | Paraxanthine-13C4,15N3 is the 13C-labeled and 15N-labeled Paraxanthine. Paraxanthine, a caffeine metabolite, provides protection against Dopaminergic cell death via stimulation of Ryanodine Receptor Channels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paraxanthine (Standard) | 99.77% | Paraxanthine (Standard) is the analytical standard of Paraxanthine. This product is intended for research and analytical applications. Paraxanthine, a caffeine metabolite, provides protection against Dopaminergic cell death via stimulation of Ryanodine Receptor Channels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paraxanthine-d6 | 98.92% | Paraxanthine-d6 is the deuterium labeled Paraxanthine. Paraxanthine, a caffeine metabolite, provides protection against Dopaminergic cell death via stimulation of Ryanodine Receptor Channels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione | 7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione is deuterium-labeled 7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paraxanthine | 99.99% | Paraxanthine, a caffeine metabolite, provides protection against Dopaminergic cell death via stimulation of Ryanodine Receptor Channels. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
